healthsystemcio.com

healthsystemCIO.com is the sole online-only publication dedicated to exclusively and comprehensively serving the information needs of healthcare CIOs.

  • About
    • Our Team
    • Advisory Panel
    • FAQs/Policies
    • Podcasts
    • Social Media
    • Contact
    • Privacy & Data Protection Policy
    • Terms of Service
  • Advertise
  • Partner Perspectives
  • Subscribe
  • Webinars
    • 4/6-Improving Data Quality
    • 4/13-Staying Trained on Key Apps
    • On-Demand Webinar Library

  • About
    • Our Team
    • Advisory Panel
    • FAQs/Policies
    • Podcasts
    • Social Media
    • Contact
    • Privacy & Data Protection Policy
    • Terms of Service
  • Advertise
  • Partner Perspectives
  • Subscribe
  • Webinars
    • 4/6-Improving Data Quality
    • 4/13-Staying Trained on Key Apps
    • On-Demand Webinar Library

FDA Expands Gene Testing for Drug Prescription

01/22/2010 By Gerry Higgins 7 Comments

“The FDA considers both unwanted harmful effects and lack of efficacy to be adverse events. When considering candidates for pharmacogenomic relabeling, the FDA evaluates the severity of the adverse reaction, the degree to which genetics predicts the reaction, and the total number of individuals likely to be affected.  These factors are important in assessing the […]

Share

Filed Under: Clinical Decision Support Tagged With: Amalga, Azyxxi, Bioinformatics, Blogs, Clinical Decision Support, FDA, Gerry Higgins, MedStar Health, Pharmacogenomics

Content by Topic

Partner Sponsors

 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Copyright © 2023 HealthsystemCIO.com.